Details of the Drug

General Information of Drug (ID: DM3L8BE)

• Drug Name: Allogeneic NK cells
• Synonyms: Allogeneic NK transfer

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 1/2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D00PBS

References

• [1] ClinicalTrials.gov (NCT04344548) Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia. U.S. National Institutes of Health.